Journals / Experimental Biomedical Research / 2020 / Cilt: 3 - Sayı: 4

Effect of single or multiple injection of platelet-rich plasma in comparison with hyaluronic acid on knee osteoarthritis

Pages
262–276
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Intraarticular PRP injections (single or three doses) were found to be more beneficial in the short term in terms of pain and functional improvement than HA injection and administration of three consecutive doses of PRP may be more effective compared to single-dose PRP administration in KOA patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To compare the effect of administration of 2 different doses of platelet rich plasma (PRP) and a single dose of hyaluronic acid (HA) preparation on pain and daily life activities of knee osteoarthritis (KOA) patients.
📊
Key Findings & Data:Method: In this nonrandomized comparative study, three groups of patients who received either a single dose of intraarticular (IA) PRP (PRP1 group), three doses of IA PRP (PRP3 group), or single dose IA HA (HA group) were included.
💡
Conclusion & Impact:Conclusion: Intraarticular PRP injections (single or three doses) were found to be more beneficial in the short term in terms of pain and functional improvement than HA injection and administration of three consecutive doses of PRP may be more effective compared to single-dose PRP administration in KOA patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: To compare the effect of administration of 2 different doses of platelet rich plasma (PRP) and a single dose of hyaluronic acid (HA) preparation on pain and daily life activities of knee osteoarthritis (KOA) patients. Method: In this nonrandomized comparative study, three groups of patients who received either a single dose of intraarticular (IA) PRP (PRP1 group), three doses of IA PRP (PRP3 group), or single dose IA HA (HA group) were included. Assessments were before treatment, and in the 3rd week and 6th week after treatment (after the final injection). The pain-visual analog scale (VAS), Euro-Qol (EQ)-5D-3L, EQVAS, and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) were used. Results: In the 3rd week, there were statistically significant differences between the PRP1-HA groups in all parameters except EQ5; between PRP3-HA groups in all parameters except EQ5 and WOMAC stiffness; and between PRP3-PRP1 groups in all parameters except EQVAS, WOMAC pain and WOMAC stiffness. In the 6th week, there were statistically significant differences between the PRP1-HA groups in all parameters except WOMAC stiffness; between PRP3-HA groups in all parameters; and between PRP3-PRP1 groups in all parameters except WOMAC pain. Conclusion: Intraarticular PRP injections (single or three doses) were found to be more beneficial in the short term in terms of pain and functional improvement than HA injection and administration of three consecutive doses of PRP may be more effective compared to single-dose PRP administration in KOA patients.

🔖

Cite This Article

DİLEKCİ, E., ÖZKUK, K., KARDEŞ, S. (2020). Effect of single or multiple injection of platelet-rich plasma in comparison with hyaluronic acid on knee osteoarthritis. Experimental Biomedical Research, Cilt: 3 - Sayı: 4, 262–276. https://ajindex.com/articles/158710

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745-59
  2. French SD, Bennell KL, Nicolson PJA, et al. What do people with knee or hip osteoarthritis need to know? an international consensus list of essential statements for osteoarthritis. Arthritis Care Res. 2015;67(6):809-16
  3. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res. 2020;72(2):149-62
  4. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578-589
  5. Bruyère O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4):3-11
  6. Fernandes L, Hagen KB, Bijlsma JWJ, et al. EULAR recommendations for the nonpharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis. 2013;72(7):1125-135
  7. Jüni P, Reichenbach S, Trelle S, et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: A randomized controlled trial. Arthritis Rheum. 2007;56(11):3610-619
  8. Paoloni J, De Vos RJ, Hamilton B, et al. Platelet-rich plasma treatment for ligament and tendon injuries. Clin J Sport Med. 2011;21(1):37-45
  9. Nguyen RT, Borg-Stein J, McInnis K. Applications of Platelet-Rich Plasma in Musculoskeletal and Sports Medicine: An Evidence-Based Approach. PM R. 2011;3(3):226-50
  10. Dold AP, Zywiel MG, Taylor DW, et al. Platelet-rich plasma in the management of articular cartilage pathology: A systematic review. Clin J Sport Med. 2014;24(1):31-43
  11. Görmeli G, Görmeli CA, Ataoglu B, et al. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebocontrolled trial. Knee Surgery, Sport Traumatol Arthrosc. 2017;25(3):958-65
  12. Zhang HF, Wang CG, Li H, et al. Intraarticular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: A meta-analysis. Drug Des Devel Ther. 2018;12:445-53
  13. Katz J, Melzack R. Measurement of pain. Surg Clin North Am. 1999;79(2):231-52
  14. EuroQol Group. EuroQol--a new faci